Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study
Titel:
Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study
Auteur:
Stein, Dan J. Ahokas, Antti Jarema, Marek Avedisova, Alla S. Vavrusova, Livia Chaban, Oleg Gruget, Céline Olivier, Valérie Picarel-Blanchot, Françoise de Bodinat, Christian